Technical Field
This invention relates generally to medical drapes, and more particularly to a drape configured to facilitate prevention of infection and other complications during medical procedures.
Background Art
Healthcare facilities are increasingly concerned about the occurrence of secondary complications occurring during medical and surgical procedures. For example, during a medical procedure on an otherwise healthy patient, such as the insertion of an intravenous catheter, there is the possibility that a secondary infection or other complication can result. As a result, more attention is being turned to establishment and maintenance of sterile fields about patients and procedure sites during medical procedures. For example, some healthcare facilities request medical professionals to check and double check certain conditions, such as whether a proper sterile field has been established or whether a proper sterile field can be maintained. Despite these warnings, it can some times be difficult to remember to check and double check each condition. Further, it can be difficult to maintain sterile fields with some currently existing equipment.
It would be advantageous to have equipment configured to reduce contamination of sterile fields during medical procedures.
Skilled artisans will appreciate that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help to improve understanding of embodiments of the present invention.
Embodiments of the invention are now described in detail. Referring to the drawings, like numbers indicate like parts throughout the views. As used in the description herein and throughout the claims, the following terms take the meanings explicitly associated herein, unless the context clearly dictates otherwise: the meaning of “a,” “an,” and “the” includes plural reference, the meaning of “in” includes “in” and “on.” Relational terms such as first and second, top and bottom, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, reference designators shown herein in parenthesis indicate components shown in a figure other than the one in discussion. For example, talking about a device (10) while discussing figure A would refer to an element, 10, shown in figure other than figure A.
A central catheter is a catheter that is placed into a large vein through which medical professionals may deliver fluids, dyes, or medications to a patient. For example, during angiogram procedures, medical professionals will insert a central catheter into an artery or vein. The catheter is then directed to the proper area within the patient. A special dye is then injected into the vessel so that the circulatory system will be visible to a radiographic camera.
Central catheters can also be used to withdraw fluids, such as blood, for testing. Central catheters can be inserted into various parts of the patient. During angiograms, catheters can be inserted into a blood vessel near the groin, such as the femoral artery or vein, but can also be placed into vessels in the arm. Placement into vessels in the arm can be advantageous in angiogram procedures that study the circulatory system about the heart, because the path through which the catheter must be guided is shorter from the arm to the heart than from the groin to the heart. Central catheters inserted into arms are generally known as “peripherally” inserted central catheters. Peripherally inserted central catheters can be placed into a patient's arm for diagnostic procedures, such as angiograms. Peripherally inserted central catheters can also be placed in a patient's arm to allow prolonged intravenous access, such as for extended antibiotic treatment, chemotherapy, and so forth. In the former case, insertion is temporary. In the latter, peripherally inserted central catheters can be left in place in the patient's arm for periods ranging from six weeks to one year.
Catheter insertion procedures, including peripherally inserted central catheter procedures, are generally performed bedside or in a diagnostic lab room by a medical professional who specializes in catheter insertion. The medical professional is frequently a specially trained nurse. One exception to bedside insertion occurs during radiology procedures, such as angiograms, where the catheter is guided and inserted by a doctor.
Regardless of who inserts the catheter, or where it is inserted, bloodstream infection is continually a concern. It will be readily understood that insertion of a foreign object, which can be on a semi-permanent basis, into a patient's vein has associated therewith a risk that bacteria or other microbes will be introduced into the bloodstream during central catheter and peripherally inserted central catheter insertion procedures. Studies have shown that such infections can be a source of death. The largest percentage of these infections occurs at the time of catheter insertion.
To combat this, some health care providers have begun to issue catheter insertion procedure requirements that are similar to those used in surgery. For example, a catheter insertion specialist must don hair covering, a mask, gloves, foot coverings, and a full-body sterile surgical gown, just as if they were entering an operating room. Such procedures also require the patient to be covered by a conventional medical drape. Such procedures attempt to ensure that a maximum barrier environment is established prior to the insertion of central lines.
While the procedures are beneficial, they are insufficient for preventing bloodstream infections during central line procedures for two reasons: First, it is frequently the case that medical personnel performing line placement are unfamiliar with “surgical” practices and aseptic techniques used during operations. Said differently, central catheter insertion personnel generally do not work in the operating room, and are therefore frequently unacquainted with operating room procedures. Accordingly, such personnel therefore frequently lack understanding of certain techniques, including correct steps in tying tourniquets and when to drape the patient. These deficiencies can cause breaks in aseptic technique. For example, tying a tourniquet too soon could cause damage to the patient. Nonetheless, in catheter insertion, procedures frequently suggest the tourniquet be tied before the sterile field is created, which is still before the medical personnel dons the equipment listed above. Thus, some medical personnel may be tempted to apply tourniquets required in central line insertion procedures too soon.
A second problem is that a single person—rather than a team—generally inserts central catheters and peripherally inserted central catheters. Consequently, the insertion specialist must juggle many items and perform many complex steps to ensure sterile fields using conventional equipment and drapes. Application of prior art drapes requires at least two people to prevent compromising the sterile field. When one person attempts to apply a drape in a catheter insertion procedure, he or she risks compromise of any sterile field that may be required for the procedure.
Embodiments of the present invention work to solve both problems by providing a full body procedural drape that is specifically configured for central catheter insertions. While peripherally inserted central catheters will be used below as an illustrative application, it will be clear to those of ordinary skill in the art having the benefit of this disclosure that the invention is not so limited. Minor modification of drapes described herein, such as slight movement and relocation of the components described below, will permit drapes configured in accordance with embodiments of the invention to be readily used for a wide variety of central line or catheterization procedures.
Embodiments of the invention described herein are configured in a modular arrangement, with a medical drape including a patient drape and a radial drape attachment. The patient drape is opaque in one embodiment, and is configured for placement over the patient. The radial drape attachment is equipped with an adhesive or other coupling that allows it to be attached to the patient drape. The radial drape attachment can be attached to the patient drape such that it extends beyond a perimeter of the patient drape in any radial alignment relative to the patient drape. In one or more embodiments, the radial drape attachment is coupled to the patient drape such that it covers a patient's arm sticking out from beneath the patient drape. The combined patient drape/radial drape attachment thus allows catheter insertion while completely maintaining a sterile field on a patient side of the medical drape.
Advantages offered by the embodiments of the invention, as compared to prior art designs, include helping medical personnel more easily apply, use, and remove the drape. Additionally, some embodiments assist in the application of tourniquets used during catheter insertion procedures. The drape assemblies described below help to ensure proper aseptic techniques. They also help in drape removal without compromising the integrity of the catheter that has been inserted into the patient. A predominant additional advantage offered by embodiments of the invention is that the drapes described below can be applied by a single person without compromising the sterile field about the patient.
Embodiments described below provide a medical drape, suitable for use in peripherally inserted central catheter and other procedures, that work as full-body drapes, and that are easy for one person to open and apply. Additionally, medical drapes described below can be universally configured for use with the right or left arm of a patient. In contrast to conventional drapes, which are fully opaque, embodiments described below include radial drape attachments that have transparent portions. The transparent portions make it possible for medical personnel to see the patient's arm through the radial drape attachment for better application and removal of tourniquets and for better insertion of catheters.
Some embodiments include tourniquets that are integrated in the radial drape attachments. Where included, the integral tourniquet prevents medical personnel from “fishing” for a tourniquet that is beneath an opaque drape, as is the case in prior art designs. The tourniquets can include closure devices on the patient side of the drape, such as snap-locking devices or buckle-type closures.
In one or more embodiments, the radial drape attachment of the medical drape includes a tool-less removal feature that allows drape components to be easily removed at the end of the procedure. The tool-less removal feature allows the radial drape attachment to “break away” from the insertion site, thereby preventing accidental tugging or pulling of the remaining catheter line.
Turning now to
Beginning with
In one or more embodiments, the patient drape 100 has a length 116 of between 95 and 110 inches, such as about 104 inches plus or minus an inch. In one embodiment, the patient drape has a width 115 of sixty-four inches, plus or minus one inch. The term “about” is used to refer to a measurement inclusive of manufacturing tolerances. Accordingly, both 104.5 and 103.1 inches would be “about” 104 inches if the manufacturing tolerances were plus or minus one inch.
In certain applications, the patient drape 100 can be configured with optional incise features 102 designed for a particular medical procedure. The incise features 102 may be apertures. In other embodiments, the incise features 102 may be fenestrations that can be opened to form apertures in the patient drape 100. For example, where the patient drape 100 is used in angioplasty procedures, a pair of incise features 102 may be disposed in a location so as to be located above a patient's groin when the patient drape 100 is placed atop a patient. This location would provide access to the patient's femoral artery or vein during the angioplasty procedure. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that the inclusion of incise features 102 is optional. Further, where included, the number and location of incise features 102 can vary based upon application.
In one embodiment, the adhesive coupling 202 is a layer of adhesive tape with a width of two inches. The adhesive portion of the adhesive tape is disposed on the patient side of the radial drape attachment layer 201. The adhesive portion can be covered with a releasable covering. When the radial drape attachment 200 is ready for use, the releasable covering can be removed to reveal the adhesive material. Pressing the adhesive material against the patient drape 100 causes the radial drape attachment 200 to be coupled to the patient drape 100. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that other coupling devices can be used for the adhesive coupling 202. Examples include hook and loop fasteners, mechanical clasps, or other fasteners. The adhesive coupling 202 need only be configured to attach the radial drape attachment 200 to the patient drape 100.
Turning briefly to
Turning back to
In one or more embodiments, the radial drape attachment 200 includes one or more apertures configured for a medical procedure. For example, the illustrative radial drape attachment 200 of
In one or more embodiments, a support layer is disposed about the fenestration 205. In the illustrative embodiment of
In one embodiment, the absorptive element 207 is arranged such that a predetermined minimum area 251 of the radial drape attachment layer 201 is disposed between the absorptive element 207 and the fenestration 205. In this illustrative embodiment, the predetermined minimum area 251 is a one and a half inch wide strip that passes about the fenestration 205 on three sides. The predetermined minimum area 251 of the radial drape attachment layer 201, which in this example is transparent, can be helpful in a variety of applications. For example, in angioplasty applications, an ultrasound technician may need to see the patient's limb through the radial drape attachment 200. If the absorptive element 207 extends to the fenestration 205, this is not possible. However, when the predetermined minimum area 251 is included, the patient's limb disposed beneath the radial drape attachment 200 becomes visible from above.
In one or more embodiments, to keep the fenestration 205 closed until needed, a releasable covering 302 may be attached over the fenestration 205. In this illustrative embodiment, the releasable covering 302 comprises a conventional medical release paper that is affixed across the fenestration 205 to the patient side of the radial drape attachment 200. One suitable means for affixing the releasable covering 302 to the radial drape attachment 200 is with a section 303 of adhesive tape. The adhesive tape can be a single-coated polyethylene medical tape, such as a medical tape manufactured by 3M (St. Paul, Minn.) as product number 1521. The 3M Medical Tape 1521 is a single-coated tape having a matte finish which includes a transparent polyethylene and is coated with a hypoallergenic, pressure sensitive acrylate adhesive and includes a liner that is silicone treated and is polyethylene coated on one side only along with a bleached Kraft paper release liner. The 3M medical tape has a tape caliper of 6.4 mil (0.16 mm) of polyethylene film tape, a backing of 5.0 mil (0.13 mm) translucent polyethylene film, an acrylate adhesive (designed for medical/surgical use), and a release liner of 83 lb poly-coated Kraft paper, with silicone on one side (6 mils/0.15 mm). The adhesion to steel of the 3M Medical Tape 1521 is 21 ounces/inch width (0.6 kg/25 mm width). Other suitable medical tapes manufactured by 3M and/or other manufacturers may be used as well. For example, where the adhesive tape is double-sided, the tape can also be used to temporarily attach the radial drape attachment 200 to the patient. This ensures that the fenestration 205 remains over the insertion site without requiring the insertion specialist to continually hold the radial drape attachment 200 in place.
In one or more embodiments, to make removal of the radial drape attachment 200 easier, a tool-less removal feature 209 can be incorporated into the radial drape attachment 200. One example of a tool-less removal feature is described in commonly assigned, co-pending patent application U.S. Ser. No. 12/188,931, filed Aug. 8, 2008, entitled “Zip Strip Draping System and Methods of Manufacturing Same,” Fred L. Allen, inventor, which is incorporated herein by reference.
In one embodiment, the tool-less removal feature 209, which is described in more detail with reference to
The adhesive tape strip is positioned along the length of the drape cut to overlap a portion of the radial drape attachment layer 201 on both sides of the drape cut to initially secure the adjoining drape cut sides together. The score line permits easy tearing of the adhesive tape strip to open the drape cut. Usage of the tool-less removal feature 209 allows the radial drape attachment 200 to be removed around a catheter that has been placed through the fenestration 205 without disturbing the catheter.
In one or more embodiments, to show medical personnel where to begin opening the tool-less removal feature 209, an indicator 213, shown in a blown-up view 250 in
Illustrative dimensions now are provided to further describe one embodiment suitable for use in peripherally inserted central catheter applications. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that these dimensions are examples only, provided to present a clearer image of one embodiment, and can readily be modified based upon application or customer demand.
In one embodiment, the radial drape attachment 200 has a length 118 of forty-eight inches, plus or minus one inch. In one embodiment, the radial drape attachment 200 has a width 253 of forty-six inches, plus or minus one inch.
In the illustrative embodiment of
Turning now to
Also as with
The radial drape attachment 500 of
Turning to
The second section 651 is disposed between the first section 650 and the adhesive coupling 602. This results in the adhesive coupling 602 being coupled to the opaque portion of the radial drape attachment 600 and the fenestration 605 being disposed along the opaque portion of the radial drape attachment layer 601, rather than along the transparent portion as was the case in
Not all radial drape attachments need to include the tool-less removal feature. Turning to
Length 703 is ten inches in one embodiment, while length 704 is twelve inches. Length 705 is twenty inches in one embodiment, while length 706 is eighteen inches. Length 707 is thirteen inches in one embodiment, while length 708 is twenty inches. Length 709 can be eight inches. Other dimensions, suitable for other applications, will be obvious to those of ordinary skill in the art having the benefit of this disclosure.
In one or more embodiments, pouches can be integrated along the radial drape attachment. In one embodiment, the pouches can be useful for temporarily storing small tools or medical implements during a medical procedure. In other embodiments, the pouches can be configured to catch fluids passing along a surface of the radial drape attachment. Catching fluids can be advantageous in that it prevents them from flowing to the floor, which can cause slippery conditions or increased probability of someone falling.
Turning now to
The radial drape attachment 900 of
The radial drape attachments 1100,1200 of
Note that the pouches shown in
Turning to
Turning to
Turning to
Turning now to
Turning now to
To this end,
The sleeve 1802 can be integrated into the radial drape attachment layer 1800 by sealing features 1901,1902 that prevent any access to the tourniquet 1801 from the patient side of the radial drape attachment. For example, where the radial drape attachment layer 1800 is the polyethylene as described above, the sleeve 1802 can also be made from polyethylene as well, with the sealing features 1901,1902 being made from thermoplastic that is integrally formed, such as by ultrasonic sealing, with the polyethylene to prevent moisture or other materials from reaching the tourniquet 1801. This preserves the sterile field on the patient side of the radial drape attachment, while providing access to the tourniquet 1801 on the non-patient side.
When included in a radial drape attachment, the patient can slip their arm through the sleeve 1802 when being covered with the drape. The tourniquet 1801 can remain loose until needed. The tourniquet 1801 can further be easily applied and released, as needed, without the fishing and uncertainty associated with prior art systems.
Turning now to
In the illustrative embodiment of
Turning to
An aperture 2104, which is configured in this illustrative embodiment as a fenestration through which a health care services provider can insert a catheter, has been placed over a peripherally inserted central catheter insertion site 2166. Accordingly, a peripherally inserted central catheter 2165 can be inserted through the aperture 2104.
This particular medical drape 2100 includes a tourniquet 2141, which has been integrated into the radial drape attachment 2101 in this illustration. The tourniquet 2141 has been tied in this embodiment by accessing ends of the tourniquet 2141 from the patient side of radial drape attachment 2101, which is also the patient side of the composite medical drape 2100. There is little or no risk of compromising the sterile field because the tourniquet 2141 passes through a sleeve that is integrated with the radial drape attachment 2101 on the patient side of the medical drape 2100.
Turning to
The method 2200 begins at step 2201, where a medical practitioner or patient obtains a medical drape. In one embodiment, the medical drape is bifurcated into two components that are attachable to each other to form the medical drape. A first portion is the a patient drape. A second portion is the radial drape attachment. The radial drape attachment has an adhesive coupling with which to adhere the radial drape attachment to the patient drape.
At step 2202, the patient drape is placed across the patient. At step 2203, the radial drape attachment is placed over a limb that extends outwardly from beneath the patient drape. Once oriented at the desired radial relationship relative to the patient drape, the radial drape attachment is affixed to the patient drape at step 2203 by adhering the adhesive coupling to the patient drape such that the radial drape attachment extends beyond a perimeter of the patient drape. Step 2203 can also include placing an aperture or fenestration of the radial drape attachment over a procedure site. Where the fenestration or aperture includes a releasable cover, this can be removed at step 2204. The user or insertion specialist is then able to insert the peripherally inserted central catheter in the insertion site at step 2205.
As noted above, in one or more embodiments the radial drape attachment of the medical drape will include an integrated tourniquet. Where this is the case, optional steps for using the integrated tourniquet can be included. For example, at step 2208 the patient's arm can be placed through the integrated sleeve. Where the tourniquet includes a coupler, step 2208 can include fastening the coupler about the patient's limb. At step 2209, at the appropriate time, the insertion specialist can cinch the tourniquet disposed within the sleeve by accessing ends of the tourniquet extending from a non-patient side of the medical drape.
Once the process is complete, the medical drape is removed from the patient at step 2207. Where the radial drape attachment of the medical drape includes a tool-less removal feature, optional step 2206 can include opening the tool-less removal feature as described above.
In the foregoing specification, specific embodiments of the present invention have been described. However, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the present invention as set forth in the claims below. Thus, while preferred embodiments of the invention have been illustrated and described, it is clear that the invention is not so limited. Numerous modifications, changes, variations, substitutions, and equivalents will occur to those skilled in the art without departing from the spirit and scope of the present invention as defined by the following claims. For example, the radial drape attachments can be configured to be opaque, while sections of the patient drape are configured to be pellucid and to define one or more apertures for central catheter insertion, such as into a vein of one of the patient's legs.
Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of present invention. The benefits, advantages, solutions to problems, and any element(s) that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as a critical, required, or essential features or elements of any or all the claims.
This application is a continuation-in-part of U.S. application Ser. No. 13/116,473, filed May 26, 2011, which is incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
313046 | Batdorf | Mar 1885 | A |
371353 | Perry | Oct 1887 | A |
850960 | O'Connoor | Apr 1907 | A |
1506332 | Bloom | Aug 1924 | A |
1980435 | Reagan | Nov 1934 | A |
2172162 | Gillette | Aug 1939 | A |
2430941 | Long | Nov 1947 | A |
2653324 | McMahon | Aug 1953 | A |
2673347 | Weiss | Mar 1954 | A |
2825902 | Breier | Mar 1958 | A |
3144661 | Buser | Aug 1964 | A |
3276036 | Carter et al. | Oct 1966 | A |
3359569 | Scrivens | Dec 1967 | A |
3397406 | Leach | Aug 1968 | A |
3399406 | Bradley | Sep 1968 | A |
3429433 | Holt | Feb 1969 | A |
3451062 | Bradley | Jun 1969 | A |
3540441 | Collins | Nov 1970 | A |
3625206 | Charnley | Dec 1971 | A |
3696443 | Taylor | Oct 1972 | A |
3707964 | Patience et al. | Jan 1973 | A |
3721999 | Goya et al. | Mar 1973 | A |
3750664 | Collins | Aug 1973 | A |
3803640 | Ericson | Apr 1974 | A |
3858243 | Pierron et al. | Jan 1975 | A |
3881474 | Krzewinski | May 1975 | A |
3881476 | Bolker et al. | May 1975 | A |
3935596 | Allen, Jr. et al. | Feb 1976 | A |
3952373 | Noorily | Apr 1976 | A |
3956048 | Nordgren | May 1976 | A |
3968792 | Small | Jul 1976 | A |
3989040 | Lofgren et al. | Nov 1976 | A |
4000521 | Zoephel et al. | Jan 1977 | A |
4017909 | Brandriff | Apr 1977 | A |
4041942 | Dougan et al. | Aug 1977 | A |
4119093 | Goodman | Oct 1978 | A |
4134398 | Scrivens | Jan 1979 | A |
4153054 | Boone | May 1979 | A |
4214320 | Belkin | Jul 1980 | A |
RE30520 | Pierron | Feb 1981 | E |
4266663 | Geraci | May 1981 | A |
4290148 | Roberts | Aug 1981 | A |
4308864 | Small et al. | Jan 1982 | A |
4323062 | Canty | Apr 1982 | A |
4334529 | Wirth | May 1982 | A |
4384573 | Elliott | May 1983 | A |
4476860 | Collins et al. | Oct 1984 | A |
4479492 | Singer | Oct 1984 | A |
4489720 | Morris et al. | Dec 1984 | A |
4523335 | Scrivens | Jun 1985 | A |
4553538 | Rafelson | Nov 1985 | A |
4561126 | Truman | Dec 1985 | A |
4569341 | Morris | Feb 1986 | A |
4596245 | Morris | Jun 1986 | A |
4616642 | Martin et al. | Oct 1986 | A |
4627427 | Arco | Dec 1986 | A |
4631756 | Scrivens | Dec 1986 | A |
4664103 | Martin et al. | May 1987 | A |
4674132 | Stein et al. | Jun 1987 | A |
4705171 | Eldridge | Nov 1987 | A |
4711236 | Glassman | Dec 1987 | A |
4745915 | Enright et al. | May 1988 | A |
4783854 | Bjorklund | Nov 1988 | A |
4829602 | Harreld et al. | May 1989 | A |
4869271 | Idris | Sep 1989 | A |
4905710 | Jones | Mar 1990 | A |
4920578 | Janzen et al. | May 1990 | A |
4942987 | Stackhouse | Jul 1990 | A |
4951318 | Harreld et al. | Aug 1990 | A |
5010592 | Skiles, Jr. | Apr 1991 | A |
5029344 | Shannon et al. | Jul 1991 | A |
5033115 | Bowling et al. | Jul 1991 | A |
5042507 | Dowdy | Aug 1991 | A |
5061246 | Anapliotis | Oct 1991 | A |
5074316 | Dowdy | Dec 1991 | A |
5097534 | Viemeister et al. | Mar 1992 | A |
5109873 | Marshall | May 1992 | A |
5135188 | Anderson et al. | Aug 1992 | A |
5136758 | Wilcox et al. | Aug 1992 | A |
5140996 | Sommers et al. | Aug 1992 | A |
5345946 | Butterworth et al. | Sep 1994 | A |
5362306 | McCarver et al. | Nov 1994 | A |
5372589 | Davis | Dec 1994 | A |
5377387 | Freed | Jan 1995 | A |
D356204 | Derrickson | Mar 1995 | S |
5410758 | Dupont et al. | May 1995 | A |
5414867 | Bowling et al. | May 1995 | A |
5417225 | Rubenstein et al. | May 1995 | A |
5444873 | Levin | Aug 1995 | A |
5533209 | Davis | Jul 1996 | A |
5605534 | Hutchison | Feb 1997 | A |
5611356 | Rothrum | Mar 1997 | A |
5674189 | McDowell et al. | Oct 1997 | A |
5707703 | Rothrum et al. | Jan 1998 | A |
5765566 | Rothrum | Jun 1998 | A |
5778889 | Jascomb | Jul 1998 | A |
5778891 | McMahan | Jul 1998 | A |
5784718 | Finnegan | Jul 1998 | A |
5816253 | Sosabee | Oct 1998 | A |
5862525 | Tankersley et al. | Jan 1999 | A |
5867825 | Scheerer | Feb 1999 | A |
5916202 | Ilaswell | Aug 1999 | A |
5973450 | Nishizawa et al. | Oct 1999 | A |
5975082 | Dowdy | Nov 1999 | A |
5985395 | Comstock et al. | Nov 1999 | A |
6049907 | Palomo | Apr 2000 | A |
6062444 | Tankersley et al. | May 2000 | A |
6105579 | Levitt et al. | Aug 2000 | A |
6115840 | Hastins | Sep 2000 | A |
6138278 | Taylor | Oct 2000 | A |
6196033 | Dowdle | Mar 2001 | B1 |
6216270 | Moquin et al. | Apr 2001 | B1 |
6244268 | Annett | Jun 2001 | B1 |
6272685 | Kumar | Aug 2001 | B1 |
6285611 | Kang | Sep 2001 | B1 |
6345622 | Chandler et al. | Feb 2002 | B1 |
6405730 | Levitt et al. | Feb 2002 | B2 |
6378136 | Matsushita | Aug 2002 | B2 |
6536636 | McDonniel | Mar 2003 | B1 |
6564386 | Fujikawa et al. | May 2003 | B2 |
6694981 | Gingles et al. | Feb 2004 | B2 |
6742522 | Baker et al. | Jun 2004 | B1 |
6820622 | Teves et al. | Nov 2004 | B1 |
6843252 | Harrison et al. | Jan 2005 | B2 |
7114500 | Bonutti | Oct 2006 | B2 |
D533982 | Graneto, III | Dec 2006 | S |
7181773 | Piraka | Feb 2007 | B1 |
7237271 | McLandrich | Jul 2007 | B1 |
7290547 | Joseph et al. | Nov 2007 | B2 |
7293654 | Wilson et al. | Nov 2007 | B1 |
7305991 | Santilli et al. | Dec 2007 | B2 |
7412728 | Alesina et al. | Aug 2008 | B2 |
D579178 | Snyder et al. | Oct 2008 | S |
7454798 | Feodoroff | Nov 2008 | B2 |
7549179 | Saied | Jun 2009 | B1 |
D598638 | Graneto, III | Aug 2009 | S |
7654266 | Corbitt, Jr. | Feb 2010 | B2 |
7673754 | Wilson, Jr. et al. | Mar 2010 | B2 |
D622479 | Herzog | Aug 2010 | S |
D622934 | Graneto, III | Sep 2010 | S |
7841020 | Mayfield et al. | Nov 2010 | B2 |
7971274 | Graneto, III | Jul 2011 | B2 |
8006836 | Trombetta | Aug 2011 | B2 |
8069495 | Kemper | Dec 2011 | B2 |
8162137 | Vellutato, Jr. et al. | Apr 2012 | B2 |
8343182 | Kirkham | Jan 2013 | B2 |
8375466 | Tasezen et al. | Feb 2013 | B2 |
8464374 | Thayer | Jun 2013 | B1 |
20020095709 | Fujikawa et al. | Jul 2002 | A1 |
20030060831 | Bonutti | Mar 2003 | A1 |
20030121522 | Gingles et al. | Jul 2003 | A1 |
20040019951 | Cioffi | Feb 2004 | A1 |
20040103904 | Auerbach et al. | Jun 2004 | A1 |
20050044608 | Ambrose et al. | Mar 2005 | A1 |
20050145254 | Aboul-Hosn et al. | Jul 2005 | A1 |
20050223468 | Hatton | Oct 2005 | A1 |
20050279366 | Adragna | Dec 2005 | A1 |
20060000002 | Bergkvist | Jan 2006 | A1 |
20060081261 | Corbin, Jr. | Apr 2006 | A1 |
20060117452 | Ambrose | Jun 2006 | A1 |
20060117456 | Griesbach | Jun 2006 | A1 |
20060191541 | Aboul-Hosn et al. | Aug 2006 | A1 |
20060236440 | Zahler | Oct 2006 | A1 |
20070102005 | Bonutti | May 2007 | A1 |
20080006279 | Bodenham | Jan 2008 | A1 |
20080023013 | Tuke et al. | Jan 2008 | A1 |
20080047567 | Bonutti | Feb 2008 | A1 |
20080178365 | Furgerson et al. | Jul 2008 | A1 |
20090277460 | Carrez et al. | Nov 2009 | A1 |
20090320177 | Lin et al. | Dec 2009 | A1 |
20100031966 | Allen | Feb 2010 | A1 |
20100138975 | Jordan et al. | Jun 2010 | A1 |
20100299805 | Graneto, III | Dec 2010 | A1 |
20100300459 | Lair | Dec 2010 | A1 |
20110024485 | Porowski | Feb 2011 | A1 |
20110154554 | Furlong | Jun 2011 | A1 |
20110167534 | Wong et al. | Jul 2011 | A1 |
20110315150 | Bream, Jr. | Dec 2011 | A1 |
20120060257 | Herzog | Mar 2012 | A1 |
20120124722 | Yadav et al. | May 2012 | A1 |
20120167896 | Stang | Jul 2012 | A1 |
20120312308 | Allen | Dec 2012 | A1 |
20130091616 | Muche et al. | Apr 2013 | A1 |
20130276204 | Pasko et al. | Oct 2013 | A1 |
20140007316 | Tommarello et al. | Jan 2014 | A1 |
20140082816 | Christopher | Mar 2014 | A1 |
20140173814 | Yadav et al. | Jun 2014 | A1 |
20140215681 | Goodman | Aug 2014 | A1 |
20150089712 | Gamble | Apr 2015 | A1 |
20150096099 | Vanneste | Apr 2015 | A1 |
20150113698 | Gregerson-Brown | Apr 2015 | A1 |
20150208741 | Pasko | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
8904426 | May 1989 | DE |
202006005966 | Oct 2006 | DE |
0166124 | Jan 1986 | EP |
2896146 | Jul 2007 | FR |
2001-510704 | Aug 2001 | JP |
8602258 | Apr 1986 | WO |
9904721 | Feb 1999 | WO |
2001030258 | May 2001 | WO |
2007083032 | Jul 2007 | WO |
WO-2011038792 | Apr 2011 | WO |
Entry |
---|
Vanatta, Amy “Non-Final Office Action”, U.S. Appl. No. 12/720,360, filed Mar. 9, 2010; dated Oct. 11, 2011. |
Harris, Raymond E., “Non-Final Office Action”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Nov. 9, 2011. |
Vanatta, Amy B., “Notice of Allowance”, U.S. Appl. No. 12/720,360, filed Mar. 9, 2012; dated Feb. 9, 2012. |
Harris, Raymond E., “Final Office Action”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Apr. 11, 2012. |
Harris, Raymond E., “NonFinal OA”, U.S. Appl. No. 12/537,961, filed Aug. 17, 2009; dated Jul. 17, 2012. |
Lee, Cheol Soo “International Search Report”, PCT/US2012/032122; Filed Apr. 4, 2012; dated Nov. 1, 2012. |
Harris, Raymond E., “Final OA”, U.S. Appl. No. 12/537,961, filed Aug. 7, 2009; dated Nov. 21, 2012. |
Byun, Sung C., “PCT Search Report”, PCT No. PCT/US2012/052079; Filed Aug. 23, 2012; dated Dec. 26, 2012. |
Hicks, Victoria “NonFinal OA”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated May 16, 2013. |
Hicks, Victoria “Final OA”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated Nov. 22, 2013,. |
3M Product Clinical Data Summary for No. 1521, 3M Plastic Medical Tape, Jan. 1996 (2 pages). |
3M Technical Information Sheet, Product No. 1521, Feb. 2007 (2 pages). |
Description and Photographs of 75-1040 Fenestrated Snap Drape (as of Oct. 6, 2008) (1 page). |
Description and Photographs of a Perforated Drape With Tear Line (as of Oct. 6, 2008) (1 page). |
Description and Photographs of D-09875-001 Snap Drape (as of Oct. 6, 2008) (1 page). |
Description and Photographs of Perforated Drapes (as of Oct. 6, 2008) (2 pages). |
European Search Report for European Applicafion No. 09167307.9 dated Oct. 11, 2010 (5 pages). |
Medical Single Coated Film Tapes Selection Guide—Polyolefin & Vinyl, Nov. 1996 (3 pages). |
“Final OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated Feb. 1, 2016. |
“First Office Action”, CN Application No. 201280046346.4; Filed Sep. 11, 2012; dated Aug. 26, 2015. |
“Medline Catalog”, Full BodyDrapes by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, K-C100 Mayo Stand Covers by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, Midline Cath Picc Kits by Medikmark; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Medline Catalog”, PICC Full Body Coverage Pack by Halyard Health; Medline Catalog; http://www.medline.com/catalog/catalog.jsp; Unknown Publication date but believed to be prior to present application filing date. |
“Notice of Allowance”, Japanese App No. 2015-531859; dated Nov. 24, 2016. |
“Office Action”, Australian Patent Application 2012304800; dated Nov. 22, 2016. |
“Office Action”, Canadian Office Action for Canadian Patent No. 2,674,951 dated May 4, 2011 (3 pages). |
“Office ACtion”, Chinese App No. 201280046346.4; dated Apr. 21, 2016. |
“Office Action”, Chinese App No. 201280046346.4; dated Oct. 21, 2016. |
“Office Action”, JP Application No. 2014-531859; dated May 2, 2016. |
Chang, Bong Ho , “PCT Search Report and Written Opinion”, PCT/US2012/054659; Filed Sep. 11, 2012; dated Feb. 26, 2013. |
Gimenez Burgos, R , “Extended European Search Report”, App No. 12834067.6-1659/2747697; Reference No. SJG/P131778EP00. |
Gimenez Burgos, R , “Extended European Search Report”, EP 12829356.0-1659/2747696; PCT/US2012052079; Reference No. SJG/P131402EP00; dated Feb. 16, 2015. |
Haden, Sally C. , “Final OA”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Jul. 17, 2013. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/276,232, filed Oct. 18, 2011; dated Apr. 8, 2013. |
Haden, Sally C. , “NonFinal OA”, U.S. Appl. No. 13/925,617, filed Jun. 24, 2013; dated Aug. 14, 2013. |
Haines, Kimberly , “Notice of Allowance”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated May 2, 2017. |
Hicks, Victoria , “Final OA”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Jan. 2, 2015. |
Hicks, Victoria , “NonFinal OA”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Jun. 13, 2014. |
Hicks, Victoria , “Notice of Allowance”, U.S. Appl. No. 13/116,473, filed May 26, 2011; dated Aug. 15, 2017. |
Pandika, Kylie , “Examination Report”, Australian Patent Application No. 2012312845; Filed Sep. 23, 2011; dated Nov. 1, 2016. |
Reed, Richard , “First Examination Report”, Australian Application No. 2012259325; Exam Request dated Mar. 5, 2015; Reference No. 35210639/GCP; dated Nov. 30, 2015. |
Wu, Jocelyn Mary , “NonFinal OA”, U.S. Appl. No. 14/086,798, filed Nov. 21, 2013; dated Sep. 24, 2015. |
“Extended European Search Report”, EP Application No. 12790027.2; PCT/US2012/032122; dated Jan. 5, 2015. |
Hicks, Victoria, “Notice of Allowance”, U.S. Appl. No. 13/589,640, filed Aug. 20, 2012; dated Dec. 19, 2017. |
Oprea, Karen, “NonFinal OA”, Canadian Application No. 2,847,495; dated Jan. 22, 2018. |
Sato, Tomoya, “NonFinal Office Action”, Japanese Patent Application No. 2017-121386; dated Dec. 27, 2017. |
Number | Date | Country | |
---|---|---|---|
20120298115 A1 | Nov 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13116473 | May 2011 | US |
Child | 13229743 | US |